Pilot Projects, 2013

Pilot Projects - Call for Applications

Letter of Intent due November 2, 2012

Full Applications due December 14, 2012

Anticipated Decision Date: January 15, 2013

Anticipated Start Date: February 1, 2013

The Center for Molecular Analysis of Disease Pathways (CMADP) at The University of Kansas provides participating investigators with research support, mentoring and access to Core Lab Services in a collegial, collaborative atmosphere.  We anticipate being able to support up to four (4) new Pilot Projects at up to $45,000 direct costs per year for one year, renewable for a second year,  starting February 1, 2013.  Applications must describe a pilot-type research project that fits well with the scientific theme of our Center and that will make good use of one or more of the CMADP Core Labs.  This competition is open to all full time, tenure-track, or tenured faculty at KU-L, KSU, WSU or KUMC whose research embraces the molecular analysis of disease pathways in the broadest sense.

Resources:


Recent News

February 2017
CMADP Project Investigators co-author Top Downloaded article in Lab on a Chip

CMADP Co-I awarded R01 from NIH National Cancer Institute

CMADP Graduate's research featured on cover of Genetics and in other journals

October 2016
CMADP Co-I receives Mathers Foundation grant

View all news »

Upcoming Events
Special seminar by Dr. Kevin W. Plaxco
Professor of Chemistry & Biochemistry
UC Santa Barbara

Wednesday, April 19, 2017 at 4:00pm
School of Pharmacy, Room 3020

"Counting molecules, dodging blood cells: real-time molecular measurements directly in the living body"
The development of technology capable of continuously tracking the levels of drugs, metabolites, and biomarkers in situ in the body would revolutionize our understanding of health and our ability to detect and treat disease. It would, for example, provide clinicians with a real-time window into organ function and would enable therapies guided by patient-specific, real-time pharmacokinetics, opening a new dimension in personalized medicine. In response my group has pioneered the development of a “biology-inspired” electrochemical approach to monitoring specific molecules that supports real-time measurements of arbitrary molecular targets (irrespective of their chemical reactivity) directly in awake, fully ambulatory subjects.
KU Today